Seroatlas · Human Serome Atlas

IDH3G

Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial

Also known as: IDH3G_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P51553
Gene
IDH3G
Ensembl
ENSG00000067829
Chromosome
X
Canonical length
393 aa
Protein class
Citric acid cycle related proteins, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
Subcellular location
Nucleoli,Mitochondria

OverviewNCBI Gene

Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. NAD(+)-dependent isocitrate dehydrogenases catalyze the allosterically regulated rate-limiting step of the tricarboxylic acid cycle. Each isozyme is a heterotetramer that is composed of two alpha subunits, one beta subunit, and one gamma subunit. The protein encoded by this gene is the gamma subunit of one isozyme of NAD(+)-dependent isocitrate dehydrogenase. This gene is a candidate gene for periventricular heterotopia. Several alternatively spliced transcript variants of this gene have been described, but only some of their full length natures have been determined. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

393 residues, UniProt reviewed canonical sequence.

>P51553|IDH3G
     1  MALKVATVAG SAAKAVLGPA LLCRPWEVLG AHEVPSRNIF SEQTIPPSAK YGGRHTVTMI
    61  PGDGIGPELM LHVKSVFRHA CVPVDFEEVH VSSNADEEDI RNAIMAIRRN RVALKGNIET
   121  NHNLPPSHKS RNNILRTSLD LYANVIHCKS LPGVVTRHKD IDILIVRENT EGEYSSLEHE
   181  SVAGVVESLK IITKAKSLRI AEYAFKLAQE SGRKKVTAVH KANIMKLGDG LFLQCCREVA
   241  ARYPQITFEN MIVDNTTMQL VSRPQQFDVM VMPNLYGNIV NNVCAGLVGG PGLVAGANYG
   301  HVYAVFETAT RNTGKSIANK NIANPTATLL ASCMMLDHLK LHSYATSIRK AVLASMDNEN
   361  MHTPDIGGQG TTSEAIQDVI RHIRVINGRA VEA

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against IDH3G can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.28
Highest tissue expression
105 nTPM

Expression across tissuesHPA

Tissue

  • skeletal muscle: 105 nTPM
  • heart muscle: 95 nTPM
  • basal ganglia: 84 nTPM
  • tongue: 78 nTPM
  • cerebral cortex: 76 nTPM
  • cerebellum: 75 nTPM

Single-cell type

  • late spermatids: 444 nCPM
  • oocytes: 212 nCPM
  • enterocytes: 196 nCPM
  • esophageal suprabasal cells: 167 nCPM
  • esophageal apical cells: 151 nCPM
  • hofbauer cells: 147 nCPM

Immune cell

  • basophil: 178 nTPM
  • non-classical monocyte: 170 nTPM
  • eosinophil: 166 nTPM
  • intermediate monocyte: 164 nTPM
  • myeloid DC: 163 nTPM
  • classical monocyte: 159 nTPM

Brain region

  • hippocampal formation: 68 nTPM
  • cerebral cortex: 63 nTPM
  • pons: 62 nTPM
  • basal ganglia: 57 nTPM
  • thalamus: 56 nTPM
  • hypothalamus: 55 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about IDH3G.

Disease | AllUniProt

Conditions IDH3G is implicated in, by any mechanism.

Disease | GeneticClinVar

2 pathogenic / likely-pathogenic of 106 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Disease | ImmuneIEDB

Conditions an epitope on IDH3G was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.71
gnomAD pLI
0.09
gnomAD missense Z
2.19
DepMap mean gene effect
-0.06
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of IDH3G in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads IDH3G as an antibody target. Whether an autoantibody or antibody against IDH3G could matter depends on whether native IDH3G is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

IDH3G is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label IDH3G as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/IDH3G. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...